Prognostic impact of day 15 blast clearance in risk-adapted remission induction chemotherapy for younger patients with acute myeloid leukemia: long-term results of the multicenter prospective LAM-2001 trial by the GOELAMS study group.

Français
Author : 
Bertoli, S ; Bories, P ; Béné, MC ; Daliphard, S ; Lioure, B ; Pigneux, A & al
Newspaper edition : 
Haematologica - Année 2014 - Volume 99 - Page 46-53 - PMID 23975179